Department of Chemistry, Imperial College London, UK.
Biomed Mater. 2010 Apr;5(2):21001. doi: 10.1088/1748-6041/5/2/021001. Epub 2010 Mar 16.
Bio-electrospraying (BES) has demonstrated great promise as a rapidly evolving strategy for tissue engineering and regenerative biology/medicine. Since its discovery in 2005, many studies have confirmed that cells (immortalized, primary and stem cells) and whole organisms (Danio rerio, Xenopus tropicalis, Caenorhabditis elegans to Drosophila) remain viable post-bio-electrospraying. Although this bio-protocol has achieved much, it suffers from one crucial problem, namely the ability to precisely control the number of cells within droplets and or encapsulations. If overcome, BES has the potential to become a high-efficiency biotechnique for controlled cell encapsulation, a technique most useful for a wide range of applications in biology and medicine ranging from the forming of three-dimensional cultures to an approach for treating diseases such as type I diabetes. In this communication, we address this issue by demonstrating the coupling of BES with droplet-based microfluidics for controlling live cell numbers within droplets and residues.
电喷射生物发生(BES)作为组织工程和再生生物学/医学领域一种快速发展的策略,已经展现出了巨大的潜力。自 2005 年发现以来,许多研究已经证实,细胞(永生化、原代和干细胞)和整个生物体(斑马鱼、爪蟾、秀丽隐杆线虫到果蝇)在电喷射后仍然具有活力。尽管该生物协议已经取得了很大的成就,但它存在一个关键问题,即无法精确控制液滴内或封装内的细胞数量。如果克服了这一问题,BES 有可能成为一种高效的生物技术,用于控制细胞的封装,这种技术在生物学和医学的广泛应用中非常有用,从三维培养的形成到治疗 1 型糖尿病等疾病的方法。在本通讯中,我们通过展示 BES 与基于液滴的微流控技术的结合,来解决这个问题,以控制液滴内和残留液中的活细胞数量。